Brief: I-Mab Announces Leadership Transitions
July 15 (Reuters) - I-Mab IMAB.O :
* I-MAB ANNOUNCES LEADERSHIP TRANSITIONS
* I-MAB - APPOINTS WEI FU AS CHAIRMAN
* I-MAB - RAJ KANNAN LEAVES AS I-MAB CEO
* I-MAB: PAMELA M. KLEIN STEPS DOWN FROM I-MAB'S BOARD AND
INTERIM
CHAIRPERSON POSITION
* I-MAB: SEAN XI-YONG FU HAS ASSUMED ROLE OF INTERIM CHIEF
EXECUTIVE OFFICER
Source text for Eikon: ID:nPn7wpB4Ra
Further company coverage: IMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview